Paper Details

  1. Home
  2. Paper Details

Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.

Author: AllenC, BomhofM, LeggN, PatelK, PazJ, VandormaelK

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Rizatriptan was more effective than naratriptan in providing earlier headache relief and pain-free status in patients with migraine. Both treatments were well tolerated.
Paper Details　
Original Abstract of the Article :
Rizatriptan (MAXALT(TM), Merck & Co., Inc.) is a selective 5-HT(1B/1D) receptor agonist with rapid oral absorption and early onset of action for the acute treatment of migraine. This randomized, double-masked, double-dummy, placebo-controlled study compared rizatriptan 10 mg to naratriptan (NARAMIG(...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000008094

データ提供：米国国立医学図書館（NLM）

Rizatriptan vs. Naratriptan: A Race Against Migraine

This research, like a race across a vast and unforgiving desert, compares the effectiveness of two different medications, rizatriptan and naratriptan, in treating migraine headaches. The authors, like seasoned desert guides, meticulously evaluated the speed and efficacy of each medication in relieving migraine pain and associated symptoms. Their findings, like a well-charted trail, provide valuable insights into the relative effectiveness of these migraine treatments.

Rizatriptan: A Faster Path to Relief

This study, like a beacon of hope in the desert of migraine pain, reveals that rizatriptan provides faster and more effective headache relief compared to naratriptan. The authors, like observant desert explorers, found that rizatriptan provided relief as early as 30 minutes after administration, with more patients experiencing complete pain relief at 2 hours compared to naratriptan. This finding, like a shortcut through the desert, suggests that rizatriptan might be a more suitable option for those seeking rapid pain relief.

Navigating the Desert of Migraine: Choosing the Right Path

This research, like a compass guiding us through the desert of migraine pain, highlights the importance of choosing the right medication to manage this debilitating condition. By understanding the relative effectiveness of rizatriptan and naratriptan, healthcare professionals can provide tailored treatment plans that best meet the needs of their patients. This study serves as a reminder that the desert of medical knowledge is full of hidden treasures, waiting to be discovered.

Dr.Camel's Conclusion

This study highlights the potential of rizatriptan to provide faster and more effective headache relief compared to naratriptan. It's like finding a shortcut through the desert, leading to a quicker and more comfortable journey to recovery. By understanding the differences between these medications, healthcare professionals can provide personalized treatment plans that help patients navigate the desert of migraine pain with greater ease.
Date :
  1. Date Completed 1999-12-23
  2. Date Revised 2017-11-01
Further Info :

Pubmed ID

10529545

DOI: Digital Object Identifier

10.1159/000008094

Related Literature

Article Analysis
・Side Effects of rizatriptan
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.